Infection Surveillance Solutions Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Infection Surveillance Software Market is Segmented by Offering (Software, Service), End User (Hospitals, Long-Term Care Facilities), and Geography (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa). The Report Offers Market Forecasts and Size in Value (USD) for all the Above Segments.

Infection Surveillance Solutions Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Infection Surveillance Solutions Market Size

Infection Surveillance Solutions Market Summary
Study Period 2019 - 2030
Market Size (2025) USD 0.72 Billion
Market Size (2030) USD 1.37 Billion
CAGR (2025 - 2030) 13.87 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration Medium

Major Players

Infection Surveillance Solutions Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Infection Surveillance Solutions Market with other markets in Technology, Media and Telecom Industry

Automation

Digital Commerce

Electronics

Information Technology

Media and Entertainment

Security & Surveillance

Infection Surveillance Solutions Market Analysis

The Infection Surveillance Solutions Market size is estimated at USD 0.72 billion in 2025, and is expected to reach USD 1.37 billion by 2030, at a CAGR of 13.87% during the forecast period (2025-2030).

The infection surveillance solutions industry continues to evolve rapidly as healthcare facilities worldwide grapple with the persistent challenge of healthcare-associated infections (HAIs). According to recent estimates, healthcare-acquired infections cost healthcare systems approximately USD 35 billion annually, with each patient admission incurring an additional cost of USD 1,100. The increasing financial burden has prompted healthcare facilities to adopt more sophisticated surveillance systems, particularly as studies indicate that anyone admitted to a hospital faces a 5% chance of contracting healthcare-acquired infections. This growing awareness has led to the development of more advanced analytical tools and automated surveillance systems that can effectively monitor and prevent infection outbreaks.


The integration of artificial intelligence and machine learning technologies has transformed the capabilities of infection surveillance solutions. Healthcare organizations are increasingly leveraging these technologies to proactively identify and prevent a range of acute and chronic health conditions with greater accuracy and practicality. The trend toward cloud-based data sharing has maximized the potential value of bioinformatics platforms for healthcare facilities, enabling comprehensive electronic records access and improved collaboration across different healthcare settings. These technological advancements have particularly benefited infection preventionists and care teams in performing ongoing resident surveillance focused on infection prevention and infection control.


Current industry data reveals concerning statistics about the prevalence of healthcare-associated infections, with the Centers for Disease Control and Prevention reporting that approximately one in 31 hospital patients has at least one healthcare-associated infection on any given day. This has spurred the development of more sophisticated surveillance tools that leverage clinical data warehouses for measuring and tracking infections. Many healthcare organizations are now implementing semi-automated electronically assisted surveillance systems (EASS) to improve efficiency and accuracy in identifying high-risk patients, moving away from traditional labor-intensive manual surveillance methods.


The market is witnessing a significant shift toward integrated surveillance platforms that combine multiple functionalities, including real-time monitoring, automated alert systems, and predictive analytics. According to the Lancet Commission for Global Surgery, approximately 11% of the global burden of disease requires surgical care or anesthesia management, highlighting the critical need for comprehensive surveillance solutions. Healthcare facilities are increasingly adopting systems that can monitor surgical site infections, antimicrobial resistance patterns, and other healthcare-associated infections while providing actionable insights for prevention and control measures. This integration of various surveillance capabilities into unified platforms is expected to continue driving market innovation and adoption, further enhancing the role of healthcare analytics in the infection surveillance solutions market.

Segment Analysis: By Offering

Software Segment in Infection Surveillance Solutions Market

The software segment dominates the infection surveillance solutions market, commanding approximately 70% of the total market share in 2024. This significant market position is driven by the increasing adoption of cloud-based and on-premise clinical surveillance software solutions across healthcare facilities worldwide. Healthcare organizations are increasingly implementing comprehensive software platforms that offer real-time monitoring, data analytics, and automated alert systems for detecting and preventing healthcare-associated infections. The software solutions are particularly valued for their ability to integrate with existing electronic health record systems, provide automated reporting capabilities, and support compliance with regulatory requirements. The segment's strong performance is further bolstered by technological advancements in artificial intelligence and machine learning capabilities, enabling more sophisticated infection pattern recognition and predictive analytics.

Market Analysis of Infection Surveillance Solutions Market: Chart for By Offering

Services Segment in Infection Surveillance Solutions Market

The services segment is emerging as the fastest-growing segment in the infection surveillance solutions market, projected to grow at approximately 15% during the forecast period 2024-2029. This robust growth is primarily driven by the increasing demand for professional services, including implementation support, maintenance, training, and consulting services. Healthcare facilities are recognizing the critical importance of expert guidance in optimizing their infection surveillance systems and ensuring maximum utility of their software investments. The growth is further accelerated by the rising complexity of healthcare IT infrastructure and the need for specialized expertise in data analytics and infection prevention protocols. Service providers are expanding their offerings to include advanced analytics support, customized training programs, and ongoing technical assistance to help healthcare organizations maintain effective infection surveillance programs.

Segment Analysis: By End User

Hospitals Segment in Infection Surveillance Solutions Market

The hospitals segment dominates the infection surveillance solutions market, accounting for approximately 47% of the total market share in 2024. This significant market position is driven by the increasing adoption of infection surveillance systems designed to continuously monitor and manage healthcare-associated infections (HAIs) data for public health assessment and early disease detection. The segment's growth is further supported by stringent government healthcare policies and initiatives for HAI prevention worldwide. Modern hospitals are increasingly implementing AI-powered surveillance systems that help health systems and public health agencies predict and prevent various chronic health concerns, including healthcare-associated infections. These advanced systems enable hospitals to proactively identify acute and chronic health conditions with greater accuracy and practicality, allowing healthcare facilities to act before clusters, outbreaks, or critical medical emergencies escalate.

Long-term Care Facilities Segment in Infection Surveillance Solutions Market

The long-term care facilities segment is projected to exhibit the highest growth rate in the infection surveillance solutions market from 2024 to 2029. This accelerated growth is primarily attributed to the increasing vulnerability of long-term care facilities to healthcare-associated infections and viral outbreaks. These facilities, which include homecare agencies, hospices, nursing homes, and assisted living facilities, are particularly susceptible to infection outbreaks due to their resident population of elderly and multimorbid patients who require continuing care. The segment's growth is further driven by the rising implementation of sophisticated surveillance solutions that enable real-time monitoring, early infection detection, and effective contact tracing capabilities. Healthcare workers in these facilities are also increasingly recognizing the importance of comprehensive infection surveillance systems in preventing the spread of pathogens and reducing antibiotic resistance cases.

Remaining Segments in End User Segmentation

The other end users segment, which primarily includes ambulatory care centers, laboratories, and academic institutes, plays a crucial role in the infection surveillance solutions market. These facilities are increasingly adopting surveillance systems to monitor surgical site infections in outpatient procedures and manage infection control in various healthcare settings. Ambulatory care centers, in particular, are showing growing interest in implementing these solutions due to the increasing complexity and volume of outpatient surgical procedures. Academic institutes and laboratories are also contributing to market growth by utilizing these systems for research purposes and monitoring potential outbreaks in educational healthcare settings. The segment's impact on the market is further enhanced by the growing emphasis on preventive care and infection control measures across all healthcare facilities.

Infection Surveillance Solutions Market Geography Segment Analysis

Infection Surveillance Solutions Market in North America

North America represents a dominant force in the infection surveillance solutions market, driven by stringent government policies for preventing hospital-associated infections and advanced healthcare infrastructure. The United States and Canada form the key markets in this region, with widespread adoption of electronic health records and clinical surveillance systems. The region's leadership position is supported by the presence of major market players, robust healthcare IT infrastructure, and an increasing focus on reducing healthcare-associated infections through systematic monitoring and prevention strategies.

Market Analysis of Infection Surveillance Solutions Market: Forecasted Growth Rate by Region

Infection Surveillance Solutions Market in the United States

The United States maintains its position as the largest market for infection surveillance solutions in North America, commanding approximately 92% of the regional infection surveillance solutions market share. The country's market dominance is attributed to its extensive healthcare network, significant healthcare IT investments, and stringent regulatory requirements for infection control. Many hospitals, including major healthcare systems, have adopted advanced infection surveillance solutions to minimize HAI incidents. The implementation of National Action Plans and increased funding from organizations like the NIH for curbing healthcare-associated infections further strengthens market growth in the country.

Infection Surveillance Solutions Market in Canada

Canada emerges as the fastest-growing market in North America, with a projected growth rate of approximately 16% during 2024-2029. The country's market expansion is driven by progressive healthcare policies and initiatives like the Coalition of Healthcare Acquired Infection Reduction (CHAIR), which aims to achieve significant reductions in healthcare-acquired infections. The Canadian Nosocomial Infection Surveillance Program (CNISP) plays a crucial role in collecting national epidemiologic and laboratory data on HAIs, contributing to market growth. The country's focus on implementing comprehensive electronic health records and infection surveillance systems across healthcare facilities continues to drive market expansion.

Infection Surveillance Solutions Market in Europe

Europe represents a significant market for infection surveillance solutions, characterized by diverse healthcare systems and varying levels of technology adoption across countries. The region's market is shaped by countries including Germany, the United Kingdom, France, Italy, and Spain, each contributing uniquely to the market landscape. The European Centre for Disease Control and Prevention's initiatives and the increasing focus on healthcare-associated infection prevention drive market growth across the region.

Infection Surveillance Solutions Market in Germany

Germany leads the European market for infection surveillance solutions, holding approximately 24% of the regional market share. The country's dominant position is supported by its high healthcare spending, with around 11.9% of GDP dedicated to health expenditure. Germany's Federal Ministry of Health's comprehensive investment programs in hospital digitalization, coupled with stringent infection control policies, drive market growth. The country's emphasis on remote patient monitoring and favorable government regulations further strengthen its market position.

Infection Surveillance Solutions Market in Italy

Italy demonstrates the highest growth potential in the European region, with a projected growth rate of approximately 15% during 2024-2029. The country's healthcare system is undergoing significant digital transformation, with increasing adoption of infection surveillance solutions. The Italian Health Ministry's national plan for tackling chronic care and the implementation of Population Health Management approaches create a favorable environment for market growth. The country's focus on improving healthcare infrastructure and infection prevention measures continues to drive market expansion.

Infection Surveillance Solutions Market in Asia-Pacific

The Asia-Pacific region represents a dynamic market for infection surveillance solutions, with significant variations in healthcare infrastructure and technology adoption across countries. China, India, and Japan emerge as key markets, each with distinct characteristics and growth patterns. The region's market is driven by increasing healthcare expenditure, growing awareness about healthcare-associated infections, and government initiatives to improve healthcare infrastructure.

Infection Surveillance Solutions Market in China

China dominates the Asia-Pacific market for infection surveillance solutions, supported by its extensive healthcare system and significant government investments in healthcare infrastructure. The country's National Center for Public Health Surveillance and Information Service plays a crucial role in modernizing healthcare operations through information technology. The National Disease Reporting System's comprehensive coverage and the government's focus on improving epidemic response capacity strengthen China's market position.

Infection Surveillance Solutions Market in India

India emerges as the fastest-growing market in the Asia-Pacific region, driven by increasing healthcare digitalization and government initiatives like the Integrated Disease Surveillance Programme. The country's focus on strengthening healthcare infrastructure and implementing surveillance systems for epidemic-prone diseases supports market growth. Collaborations between healthcare institutions and international organizations for implementing healthcare-associated infection surveillance systems further boost market expansion.

Infection Surveillance Solutions Market in Latin America

The Latin American market for infection surveillance solutions shows steady growth potential, driven by increasing awareness about healthcare-associated infections and government initiatives for improving healthcare infrastructure. The region faces unique challenges in healthcare delivery but demonstrates growing adoption of infection surveillance solutions. While Mexico and Brazil emerge as key markets, with Mexico leading in market size and Brazil showing the fastest growth, the entire region shows potential for market expansion through increased awareness programs and healthcare modernization efforts.

Infection Surveillance Solutions Market in the Middle East & Africa

The Middle East & Africa region presents a growing market for infection surveillance solutions, characterized by varying levels of healthcare infrastructure development across countries. The market is driven by government initiatives to improve healthcare quality and reduce healthcare-associated infections. Saudi Arabia emerges as the largest market in the region, supported by significant healthcare IT investments, while the United Arab Emirates shows the fastest growth potential due to its rapid healthcare digitalization efforts and implementation of advanced surveillance systems.

Infection Surveillance Solutions Industry Overview

Top Companies in Infection Surveillance Solutions Market

The infection surveillance solutions market features established players like Cerner Corporation, Epic Systems, Vigilanz Corporation, Becton Dickinson & Co., Premier Inc., and IBM Corporation leading innovation and market development. These companies are heavily investing in artificial intelligence and cloud-based surveillance capabilities to enhance their offerings, with a particular focus on real-time monitoring and predictive analytics for healthcare-associated infections. The industry has seen significant product development around integrated platforms that combine infection control, clinical surveillance, and regulatory compliance functionalities. Companies are pursuing strategic partnerships with healthcare providers and expanding their geographical presence through both organic growth and acquisitions. There is also an emerging trend of developing specialized solutions for pandemic preparedness and contact tracing capabilities, accelerated by recent global health challenges.

Market Dominated by Healthcare Technology Specialists

The infection surveillance solutions market exhibits a moderate level of consolidation, with a mix of large healthcare technology conglomerates and specialized infection control software providers competing for market share. The leading players have established strong relationships with healthcare institutions through their comprehensive electronic health record systems and clinical decision support systems market platforms, creating significant barriers to entry. The market has witnessed considerable merger and acquisition activity, with larger companies acquiring specialized surveillance software providers to enhance their capabilities and expand their customer base.


The competitive dynamics are characterized by a strong presence of regional players in specific geographic markets, particularly in North America and Europe, where healthcare infrastructure and regulatory requirements drive demand. Market participants are increasingly focusing on developing end-to-end solutions that integrate with existing healthcare IT infrastructure, rather than standalone surveillance products. The industry has also seen the emergence of strategic partnerships between software providers and healthcare institutions to develop more sophisticated and customized surveillance solutions.

Innovation and Integration Drive Market Success

Success in the infection surveillance solutions market increasingly depends on providers' ability to deliver comprehensive, integrated platforms that can seamlessly connect with existing healthcare IT systems while offering advanced analytics capabilities. Incumbent companies are focusing on expanding their product portfolios through internal development and strategic acquisitions, while also investing in cloud-based delivery models and artificial intelligence capabilities to maintain their competitive edge. The ability to provide solutions that address specific regulatory requirements and demonstrate clear return on investment through reduced healthcare-associated infections has become crucial for market success.


For new entrants and smaller players, the path to gaining market share lies in developing specialized solutions that address specific gaps in current offerings or target underserved market segments. Companies must navigate complex regulatory requirements while maintaining high standards of data security and privacy. The increasing focus on value-based healthcare and the growing importance of infection prevention in healthcare settings create opportunities for innovative solutions that can demonstrate clear clinical and economic benefits. Success also depends on building strong relationships with healthcare providers and maintaining high levels of customer support and service.


The infection surveillance solutions industry is witnessing a transformation driven by the integration of healthcare analytics, which is pivotal in enhancing infection prevention strategies. As the infection surveillance solutions market cap continues to grow, stakeholders are keen on leveraging these advancements to optimize healthcare outcomes.

Infection Surveillance Solutions Market Leaders

  1. IBM Corporation (Truven Health Analytics)

  2. Gojo Industries Inc

  3. VigiLanz Corporation

  4. Cerner Corporation

  5. RL Datix Ltd

  6. *Disclaimer: Major Players sorted in no particular order
Infection Surveillance Solutions Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Infection Surveillance Solutions Market News

  • June 2024: The Asian Development Bank (ADB) approved a USD 170 million policy-based loan to bolster India's health sector preparedness for future pandemics. The initiative focuses on strengthening disease surveillance systems to swiftly tackle public health threats. Additionally, it will set up laboratory networks to monitor infectious diseases across states, union territories, and metropolitan regions.
  • February 2024: Inovalon, a provider of cloud-based software solutions that empower data-driven healthcare, has announced its collaboration with VigiLanz. VigiLanz, an Inovalon solution, is recognized as a provider of SaaS-based clinical surveillance and patient safety technology.

Infection Surveillance Solutions Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Stringent Government Policies for Preventing Hospital Associated Infections
    • 4.2.2 Rise in the Number of Surgeries
  • 4.3 Market Restraints
    • 4.3.1 Reluctance Among Medical Professionals to Adopt Advanced Healthcare Tools
  • 4.4 Industry Value Chain Analysis
  • 4.5 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.5.1 Threat of New Entrants
    • 4.5.2 Bargaining Power of Buyers/Consumers
    • 4.5.3 Bargaining Power of Suppliers
    • 4.5.4 Threat of Substitute Products
    • 4.5.5 Intensity of Competitive Rivalry

5. TECHNOLOGY SNAPSHOT AND INDUSTRY POLICY

6. MARKET SEGMENTATION

  • 6.1 By Offering
    • 6.1.1 Software
    • 6.1.1.1 On-Premise
    • 6.1.1.2 Cloud
    • 6.1.2 Services
    • 6.1.2.1 Maintenance and Support
    • 6.1.2.2 Consultation and Training
    • 6.1.2.3 Implementation Service
  • 6.2 By End-User
    • 6.2.1 Hospitals
    • 6.2.2 Long-term Care Facilities
    • 6.2.3 Other End Users
  • 6.3 By Geography***
    • 6.3.1 North America
    • 6.3.1.1 United States
    • 6.3.1.2 Canada
    • 6.3.2 Europe
    • 6.3.2.1 United Kingdom
    • 6.3.2.2 Germany
    • 6.3.2.3 France
    • 6.3.2.4 Italy
    • 6.3.2.5 Spain
    • 6.3.3 Asia
    • 6.3.3.1 China
    • 6.3.3.2 India
    • 6.3.3.3 Japan
    • 6.3.4 Australia and New Zealand
    • 6.3.5 Latin America
    • 6.3.6 Middle East and Africa

7. COMPETITIVE LANDSCAPE

  • 7.1 Company Profiles*
    • 7.1.1 IBM Corporation (Truven Health Analytics)
    • 7.1.2 Gojo Industries Inc.
    • 7.1.3 VigiLanz Corporation
    • 7.1.4 Cerner Corporation
    • 7.1.5 RL Datix Ltd
    • 7.1.6 DEB Group Ltd (SC Johnson & Son)
    • 7.1.7 Epic Systems Corporation
    • 7.1.8 Baxter International Inc. (ICNet International)
    • 7.1.9 Becton, Dickinson and Company
    • 7.1.10 Theradoc (Premier Inc)

8. INVESTMENT ANALYSIS

9. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
*** In the Final Report Asia, Australia and New Zealand will be Studied Together as 'Asia Pacific'
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Infection Surveillance Solutions Industry Segmentation

The demand for infection surveillance has been on the rise as the need to curb hospital-acquired infections and other epidemics is intensifying. Infection surveillance solutions are designed to continuously monitor and interpret health data to ensure accurate implementation of preventive measures. The major factors contributing to the growth of this market include an increase in the incidence of HAIs and a growth in the number of surgeries coupled with government protocols for the prevention of HAIs.

The infection surveillance solutions market is segmented by offering (software and services), end-user (hospitals, long-term care facilities, and other end-users), and geography (Europe, Asia-Pacific, and the Rest of the World). The report offers market forecasts and size in value (USD) for all the above segments.

By Offering Software On-Premise
Cloud
Services Maintenance and Support
Consultation and Training
Implementation Service
By End-User Hospitals
Long-term Care Facilities
Other End Users
By Geography*** North America United States
Canada
Europe United Kingdom
Germany
France
Italy
Spain
Asia China
India
Japan
Australia and New Zealand
Latin America
Middle East and Africa
Need A Different Region or Segment?
Customize Now

Infection Surveillance Solutions Market Research FAQs

How big is the Infection Surveillance Solutions Market?

The Infection Surveillance Solutions Market size is expected to reach USD 0.72 billion in 2025 and grow at a CAGR of 13.87% to reach USD 1.37 billion by 2030.

What is the current Infection Surveillance Solutions Market size?

In 2025, the Infection Surveillance Solutions Market size is expected to reach USD 0.72 billion.

Who are the key players in Infection Surveillance Solutions Market?

IBM Corporation (Truven Health Analytics), Gojo Industries Inc, VigiLanz Corporation, Cerner Corporation and RL Datix Ltd are the major companies operating in the Infection Surveillance Solutions Market.

Which is the fastest growing region in Infection Surveillance Solutions Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Infection Surveillance Solutions Market?

In 2025, the North America accounts for the largest market share in Infection Surveillance Solutions Market.

What years does this Infection Surveillance Solutions Market cover, and what was the market size in 2024?

In 2024, the Infection Surveillance Solutions Market size was estimated at USD 0.62 billion. The report covers the Infection Surveillance Solutions Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Infection Surveillance Solutions Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Infection Surveillance Solutions Market Research

Mordor Intelligence provides a comprehensive analysis of the infection surveillance solutions market. We leverage our extensive expertise in healthcare analytics and infection control research. Our latest report examines the evolving landscape of hospital infection control and antimicrobial stewardship. It provides detailed insights into clinical decision support systems and their implementation. The report is available in an easy-to-read PDF format for download. It covers crucial aspects of disease surveillance and healthcare surveillance. This offers stakeholders a thorough understanding of market dynamics and growth opportunities in the healthcare analytics industry.

Our analysis benefits healthcare providers, technology vendors, and investors by delivering actionable insights into infection prevention strategies and epidemiology software applications. The report extensively covers developments in clinical surveillance software and healthcare compliance monitoring systems. It also examines the crucial role of ISS solutions in modern healthcare facilities. Stakeholders gain valuable perspectives on infection control market trends and healthcare analytics market projections. Additionally, it explores the integration of advanced clinical decision support system market solutions. This enables informed decision-making and strategic planning in this rapidly evolving sector.